IM Cannabis Corp.

IM Cannabis Corp. is an international medical cannabis company headquartered in Kibbutz Glil Yam, Israel. The company's core business involves the importation, distribution, and sale of medical cannabis products. IM Cannabis aims for sustainable profitability through active cost management and margin improvement, with a strategic focus on becoming a global high-quality cannabis player. As of late September 2026, the company has divested its European-focused operations and is concentrating its resources on its medical cannabis platform in Israel.

IM Cannabis provides medical cannabis dried flowers and full-spectrum cannabis extracts under brands such as IMC, BLKMT, and LOT420. In Israel, its ecosystem includes medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs to ensure safe delivery and quality control throughout the value chain. The company primarily serves medical patients in the Israeli market.

Recent significant news includes the September 29, 2026, closing of the sale of IMC Holdings and its European operations, signaling a strategic pivot to its Israeli market. The company also recently regained compliance with Nasdaq's minimum bid price requirement. Oren Shuster serves as the Chief Executive Officer, leading IM Cannabis in its refined market strategy.